A Single Centre, Double-Blind, Placebo Controlled Crossover Study in Elderly Male Subjects to Investigate the Plarmacodynamic Interaction of VA106483 Administered Concomitanctly With Alpha-Blocker Therapy.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Alpha adrenergic receptor antagonists; Fedovapagon
- Indications Nocturia
- Focus Pharmacodynamics
- 09 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 May 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.